(Q37709198)

22 August 2017

1 reference

title

The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis (English)

1 reference

22 August 2017

0 references

0 references

1 reference

C J Edwards

1

1 reference

22 August 2017

E Williams

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

13 March 2010

1 reference

Osteoporosis International

22 August 2017

published in

1 reference

22 August 2017

volume

21

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

1287-1293

1 reference

Risk factors for osteoporotic fractures in elderly men.

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-010-1192-7

Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-010-1192-7

Osteoporosis and inflammation

21 January 2018

1 reference

12 December 2020

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

1 reference

12 December 2020

Immunologic aspects of osteoporosis

1 reference

12 December 2020

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Tumour necrosis factor blockade and the risk of osteoporosis: back to the future

1 reference

12 December 2020

Fractures in rheumatoid arthritis: an evaluation of associated risk factors

1 reference

12 December 2020

Rheumatic diseases: the effects of inflammation on bone

1 reference

12 December 2020

Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis

1 reference

12 December 2020

Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.

1 reference

12 December 2020

Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study.

1 reference

12 December 2020

Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models

1 reference

12 December 2020

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

1 reference

12 December 2020

Femoral neck osteopenia in patients with inflammatory bowel disease.

1 reference

12 December 2020

The role of T cells in osteoporosis, an update.

1 reference

12 December 2020

Vertebral strength changes in rheumatoid arthritis patients treated with alendronate, as assessed by finite element analysis of clinical computed tomography scans: a prospective randomized clinical trial

1 reference

12 December 2020

Extra-articular manifestations and complications of rheumatoid arthritis

1 reference

12 December 2020

Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.

1 reference

12 December 2020

1 reference

12 December 2020

The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis

1 reference

12 December 2020

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club

1 reference

12 December 2020

Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck

1 reference

12 December 2020

Co-morbidity in rheumatoid arthritis

1 reference

12 December 2020

Mechanisms of glucocorticoid action in bone

1 reference

12 December 2020

Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion

1 reference

12 December 2020

Fractures after rheumatoid arthritis. A population-based study

1 reference

12 December 2020

Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study

1 reference

12 December 2020

Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis

1 reference

12 December 2020

RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro

1 reference

12 December 2020

Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study

1 reference

12 December 2020

The immune response. 2. Systemic mediators of inflammation

1 reference

12 December 2020

Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis

1 reference

12 December 2020

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

1 reference

12 December 2020

Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study

1 reference

12 December 2020

Understanding osteoporosis

1 reference

12 December 2020

Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis

1 reference

12 December 2020

Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis.

1 reference

12 December 2020

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 reference

12 December 2020

Evolving concepts of rheumatoid arthritis

1 reference

12 December 2020

Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms

1 reference

12 December 2020

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

1 reference

12 December 2020

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

1 reference

12 December 2020

Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis

1 reference

12 December 2020

Epidemiology of osteoporosis in rheumatic diseases.

1 reference

12 December 2020

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

1 reference

12 December 2020

Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system

1 reference

12 December 2020

Osteoporosis therapies for rheumatoid arthritis patients: minimizing gastrointestinal side effects

1 reference

12 December 2020

Bone mass measurement and bone metabolism in rheumatoid arthritis: a review

1 reference

12 December 2020

The paradigm of IL-6: from basic science to medicine

1 reference

12 December 2020

Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women

1 reference

12 December 2020

IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures

1 reference

12 December 2020

The worldwide problem of osteoporosis: insights afforded by epidemiology

1 reference

12 December 2020

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.

1 reference

12 December 2020

Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis

1 reference

12 December 2020

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

1 reference

12 December 2020

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

1 reference

12 December 2020

10.1007/S00198-010-1192-7

Identifiers

DOI

1 reference

22 August 2017

1 reference